Diabetes 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline Xu et al. Diabetes Metab. Res. Rev. 2022;e3554 Read More
Diabetes 12-Lipoxygenase Products Reduce Insulin Secretion and β-Cell Viability in Human Islets Ma et al. J. Clin. Endocrinol. Metab. 2010;95:887 Read More
Diabetes Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications Dobrian et al. Pharmacol. Ther. 2019;195:100 Read More
Diabetes Elevated 12-hydroxyeicosatetraenoic acid (12-HETE) levels in serum of individuals with newly diagnosed Type 1 diabetes Hennessy et al. Diabet. Med. 2017;34:292 Read More
Diabetes Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes Grzesik et al. J. Clin. Endocrinol. Metab. 100, E387 Read More
Diabetes 12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic Islets Ma et al. Clin. Endocrinl. Metab. 2017;102:2789 Read More
Diabetes Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes Piñeros et al. Cell Reports 2022;39:13,111011 Read More